Aytu Biopharma (AYTU) Profit After Tax Growth (5y) (2019 - 2025)
Aytu Biopharma (AYTU) Profit After Tax Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.18% |
| Sep 30, 2025 | 19.70% |
| Jun 30, 2025 | -41.26% |
| Mar 31, 2025 | 22.42% |
| Dec 31, 2024 | 41.53% |
| Sep 30, 2024 | 18.12% |
| Jun 30, 2024 | 44.85% |
| Mar 31, 2024 | 12.64% |
| Dec 31, 2023 | 45.69% |
| Sep 30, 2023 | -18.70% |
| Jun 30, 2023 | -45.39% |
| Mar 31, 2023 | -20.64% |
| Dec 31, 2022 | -12.75% |
| Sep 30, 2022 | 30.25% |
| Jun 30, 2022 | -18.97% |
| Mar 31, 2022 | -59.17% |
| Dec 31, 2021 | -19.11% |
| Sep 30, 2021 | -37.22% |
| Jun 30, 2021 | -4.43% |
| Dec 31, 2020 | -23.31% |